Understanding the click method PDL has become aware of a number of adverse events and health consequences from the popularised method of OZEMPIC® (semaglutide) administration known as “counting clicks”. OZEMPIC solution is available in pre-filled multidose pens in 1.5mL and 3mL sizes for subcutaneous administration. Both pens contain semaglutide 1.34mg/mL. OZEMPIC dosing is once weekly, starting at 0.25mg, increasing to 0.5mg after 4 weeks, and to 1mg weekly as prescribed. OZEMPIC dosing is achieved by turning the dose selector on the device until the counter displays either 0.25mg or…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Staying vaccination-ready
26 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more
What pharmacists need to know about the new intranasal flu vaccine (FluMist®)
4 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more
Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more

It's time to renew your PDL membership for the year ahead.

Renew your PDL membership now and take a moment to review your Practice Profile, as updates have been made to our areas of practice. You can log in to the member portal using your email address or mobile number.